Literature DB >> 11082068

Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects.

G A Jelinek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11082068      PMCID： PMC1118996          DOI： 10.1136/bmj.321.7271.1236

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Financial incentives to change emergency service performance.

Authors:  G A Jelinek; C J Baggoley
Journal:  Med J Aust       Date:  1999-09-06       Impact factor: 7.738

2.  Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review.

Authors:  M R Tramèr; J E Williams; D Carroll; P J Wiffen; R A Moore; H J McQuay
Journal:  Acta Anaesthesiol Scand       Date:  1998-01       Impact factor: 2.105

Review 3.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 4.  Overcrowding in the nation's emergency departments: complex causes and disturbing effects.

Authors:  R W Derlet; J R Richards
Journal:  Ann Emerg Med       Date:  2000-01       Impact factor: 5.721

5.  ED overcrowding in Taiwan: facts and strategies.

Authors:  F Y Shih; M H Ma; S C Chen; H P Wang; C C Fang; R S Shyu; G T Huang; S M Wang
Journal:  Am J Emerg Med       Date:  1999-03       Impact factor: 2.469

6.  Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial.

Authors:  T H Rainer; P Jacobs; Y C Ng; N K Cheung; M Tam; P K Lam; R Wong; R A Cocks
Journal:  BMJ       Date:  2000-11-18

7.  Increased health care costs associated with ED overcrowding.

Authors:  P Krochmal; T A Riley
Journal:  Am J Emerg Med       Date:  1994-05       Impact factor: 2.469

8.  Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.

Authors:  B L Strom; J A Berlin; J L Kinman; P W Spitz; S Hennessy; H Feldman; S Kimmel; J L Carson
Journal:  JAMA       Date:  1996-02-07       Impact factor: 56.272
  8 in total
  6 in total

1.  Patterns of illness and injury encountered in amateur ocean yacht racing: an analysis of the British Telecom Round the World Yacht Race 1996-1997.

Authors:  C J S Price; T J W Spalding; C McKenzie
Journal:  Br J Sports Med       Date:  2002-12       Impact factor: 13.800

2.  Ketorolac Use Shortens Hospital Length of Stay After Bariatric Surgery: a Single-Center 5-Year Experience.

Authors:  Kamyar Hariri; Elizabeth Hechenbleikner; Matthew Dong; Subhash U Kini; Gustavo Fernandez-Ranvier; Daniel M Herron
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 3.  The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.

Authors:  Ali Pourmand; Gregory Jasani; Courtney Shay; Maryann Mazer-Amirshahi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

4.  Anesthetic efficacy of ketamine, ketamine-tramadol and ketamine-ketorolac in chicks.

Authors:  Y J Mousa; M H I Al-Zubaidy
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

Review 5.  Managing acute pain in children presenting to the emergency department without opioids.

Authors:  Corrie E Chumpitazi; Cindy Chang; Zaza Atanelov; Ann M Dietrich; Samuel Hiu-Fung Lam; Emily Rose; Tim Ruttan; Sam Shahid; Michael J Stoner; Carmen Sulton; Mohsen Saidinejad
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-03-12

6.  Sedation, Analgesia, and Neuromuscular Blockade: An Assessment of Practices From 2009 to 2016 in a National Sample of 66,443 Pediatric Patients Cared for in the ICU.

Authors:  Anita K Patel; Eduardo Trujillo-Rivera; Farhana Faruqe; Julia A Heneghan; T Elizabeth Workman; Qing Zeng-Treitler; James Chamberlain; Hiroki Morizono; Dongkyu Kim; James E Bost; Murray M Pollack
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.971
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.